$HIMS (-1,68 %) falls (why?) Here is the answer:
The FDA released a new decision today stating that the shortage of tirzepatide injection $LLY (+1,78 %) from Eli Lilly has been resolved.
Is this drastic for Hims? No they don't sell tirzepatide directly but compounded semaglutide which is still allowed to be sold.
The only fear is that this could also be withdrawn by the FDA in the near future.
